TickerStat.comwe like data

Bioadaptives, Inc. (BDPT)

Price$0.0015Cached quote
BDPTOTC
Loading local price history

Financial charts

Revenue

Net income

Total cash / debt

CashTotal debt

Financial statements

11 annual periodsNewest to oldest
20252024202320222021202020192018201520142013
Revenue$18,278$12,669$28,565$17,176$19,776$16,327$9,934————
Gross profit$12,497$4,030$10,819$7,126$10,105$6,095$4,885————
Gross margin68.37%31.81%37.88%41.49%51.10%37.33%49.17%————
Operating expenses$1.1M$606,120$239,740$429,026$646,186$260,421$239,292$657,941$227,276$2.4M$18,779
Operating income−$1.0M−$602,090−$228,921−$421,900————−$227,276−$2.4M−$18,779
Operating margin−5,701.79%−4,752.47%−801.40%−2,456.33%———————
EBITDA−$1.0M−$600,149−$521,401−$544,301————−$226,748−$2.4M—
EBITDA margin−5,679.90%−4,737.15%−1,825.31%−3,168.96%———————
Net income−$1.6M−$899,161−$712,466−$895,570−$1.0M−$847,244−$238,927−$1.4M−$227,432−$2.6M−$18,279
Net profit margin−8,523.35%−7,097.33%−2,494.19%−5,214.08%−5,309.20%−5,189.22%−2,405.14%————
Basic EPSper basic share-$0.15-$0.11-$0.12-$1.50—-$0.04-$0.01-$0.08-$0.02-$0.21$0.00
Diluted EPSper diluted share-$0.15-$0.11-$0.12-$1.50—-$0.04-$0.01-$0.08-$0.02-$0.21—
Review official source filings ↗

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys3$311.1K disclosed value
Sells (SEC code S)0$0.00 disclosed value
3 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Apr 9, 2025Form 4FRISSORA MARK PDirectorBuyOption to Purchase Common Stock · derivative1——1
Apr 9, 2025Form 4FRISSORA MARK PDirectorBuySeries D Convertible Preferred Stock · derivative39.9K$7.52$299.8K44.4K
Nov 22, 2024Form 4Dissanayake Gimhana SasankaDirectorBuyCommon125.0K$0.09$11.3K125.0K
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about BDPT yet. Start the conversation.

Write the first post